IP Library › Granted Patent US 9,393,111
Granted Patent B2
US 9,393,111 · App. 14/279,511 · Granted Jul 19, 2016

Device and method for mitral valve regurgitation treatment

Inventors: Jianlu Ma (Irvine, CA); Yong Huo (Beijing, CN)
Assignee: Sino Medical Sciences Technology Inc.
A61F2/2418A61F2/2412A61F2/2409A61F2220/005A61F2220/0008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,393,111
App. No.
14/279,511
Granted
Jul 19, 2016
Kind
B2
Abstract

A mitral valve replacement device is adapted to be deployed at a mitral valve position in a human heart. The device has an atrial flange defining an atrial end of the device, a valve body defining a ventricular end of the device, and an annulus support that connects the atrial flange and the valve body, the annulus support including a ring of tabs extending radially therefrom and adapted to engage the native mitral annulus and/or the native leaflet(s) of the human heart. The atrial flange can be seated in the atrium above the native mitral valve annulus in a human heart, and the ring of tabs can engage the native mitral annulus in a manner where the atrial flange and tabs provide a clipping effect to secure the mitral valve replacement device at the native mitral valve position.

Claims (28)

1. A mitral valve replacement device adapted to be deployed at a mitral valve position in a human heart, comprising:

an atrial flange defining an atrial end of the device;

a valve body defining a ventricular end of the device;

an annulus support that connects the atrial flange and the valve body, the annulus support including a ring of tabs extending radially therefrom, and a ring of U-shaped sections extending radially outwardly and alternating with the tabs;

wherein the atrial flange has a diameter greater than the diameter of the valve body, and the annulus support has a diameter between that of the diameter of the atrial flange and the diameter of the valve body.

2. The device of claim 1 , further including a leaflet structure positioned at the valve body.

3. The device of claim 1 , further including at least one tail extending from the ventricular end of the valve body.

4. The device of claim 1 , further including a neck positioned between the atrial flange and the ring of U-shaped sections.

5. A mitral valve replacement device adapted to be deployed at a mitral valve position in a human heart, comprising;

an atrial flange defining an atrial end of the device;

a valve body defining a ventricular end of the device;

an annulus support that connects the atrial flange and the valve body, the annulus support including a ring of tabs extending radially therefrom;

wherein the atrial flange has a diameter greater than the diameter of the valve body, and the annulus support has a diameter between that of the diameter of the atrial flange and the diameter of the valve body; and

at least one clip extending from the annulus support.

6. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is covered with tissue.

7. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is covered with fabric.

8. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is covered with tissue and fabric.

9. The device of claim 8 , wherein the tissue and fabric are comprised of a layer of combined tissue and fabric.

10. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is coated with a biocompatible adhesive.

11. The device of claim 5 , further including a leaflet structure positioned at the valve body.

12. The device of claim 5 , further including at least one tail extending from the ventricular end of the valve body.

13. The device of claim 5 , wherein the annulus support includes a ring of U-shaped sections extending radially outwardly and alternating with the tabs.

14. The device of claim 13 , further including a neck positioned between the atrial flange and the ring of U-shaped sections.

15. The device of claim 5 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is covered with tissue.

16. The device of claim 5 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is covered with fabric.

17. The device of claim 5 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is covered with tissue and fabric.

18. The device of claim 17 , wherein the tissue and fabric are comprised of a layer of combined tissue and fabric.

19. The device of claim 5 , wherein at least a portion of one or more of the atrial flange, the annulus support and valve body is coated with a biocompatible adhesive.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2024
From: SINOMED CARDIOVITA TECHNOLOGY INC.
To: SINO MEDICAL SCIENCES TECHNOLOGY INC.
Reel/Frame 067875/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2021
From: SINO MEDICAL SCIENCES TECHNOLOGY INC.
To: SINOMED CARDIOVITA TECHNOLOGY INC.
Reel/Frame 055501/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2014
From: MA, JIANLU; HUO, YONG
To: SINO MEDICAL SCIENCES TECHNOLOGY, INC.
Reel/Frame 033884/0272 →
Continuity (2)
Provisional Application 61927490 · Jan 15, 2014
Related Publication 20150196390A1 · Jul 16, 2015